Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-16

Clinical Trial Update: Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1 [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating buprenorphine and naloxone for heroin dependence has completed. The record lists the study status as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone (Naloxone)
  • buprenorphine (buprenorphine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Heroin Dependence, Substance-Related Disorders | Phase 3 | Status: COMPLETED